GJA1 and Alzheimer disease: Our data in the AD microfluidic system robustly support an increased astrocyte reactivity, based on the altered morphological changes and augmented GFAP, GJA1, AGER, and S100B gene expression levels together with their correspondent protein immunofluorescence detection, commonly identified in AD (Monterey et al., 2021).